Healthcare could become an early AI 'winner,' strategist says
U.S. Bank Asset Management Group senior investment strategist Rob Haworth discusses healthcare as a lagging sector benefiting from A.I. advancements on 'The Claman Countdown.'
Data centers are 'lowering costs' for the average American, Manhattan Institute economist says
Manhattan Institute research director Judge Glock discusses the debate over A.I. data centers in the United States on 'The Bottom Line.'
AI trade is a multi-year 'mega trend': Jan van Eck
VanEck CEO Jan van Eck discusses an A.I. chip stock drop as tech sectors face bearish pressure on 'The Claman Countdown.'
Lenovo powers FIFA World Cup with real-time AI infrastructure
Lenovo international markets president Matt Zielinski reveals how artificial intelligence is transforming the FIFA World Cup experience on ‘The Claman Countdown.’
Social media fuels 'health FOMO' amid wellness trends
Jillian Michaels critiques extreme 'healthmaxxing' as over-the-top, advocating for basic habits. Brian Brenberg warns that social media creates a "Health FOMO," leading to unattainable standards and diminished happiness for those who try to keep up.
There is a campaign underway to derail US efforts on AI: Charles Payne
FOX Business host Charles Payne discusses the U.S. artificial intelligence race on 'Making Money.'
AI infrastructure boom: Key companies capitalizing on the AI buildout
Walser Wealth Management CIO Rebecca Walser discusses key companies capitalizing on the A.I. buildout and other market opportunities on ‘Making Money.’
Trump is 'right' to blast NY suspension of data centers: Zumarraga
Donald Trump criticizes New York's one-year suspension of AI data center construction, calling it a 'terrible decision.'
This is a way for Americans to fight Google, Amazon: Dagen McDowell
Dagen McDowell explains how local opposition to data centers is rooted in public backlash against big tech companies like Google and Amazon, who are perceived as getting rich off user data.
Taiwan Semiconductor boosts investment in Arizona fabs as chip boom continues
Taiwan Semiconductor (TSMC) reports a record-breaking quarter and announces massive investment in Arizona fabs. Lou Basenese confirms the chip boom is far from over, urging investors to "buy the dip" despite current market volatility in chip stocks.
Louis Navellier predicts a 'good' upcoming quarter
Louis Navellier provides his analysis on current market trends, including semiconductor and big tech performance, Q2 earnings expectations, the Fed's approach to inflation and interest rates, and investment opportunities in energy and materials.
Lou Basenese: My SpaceX buy zone is around $100 after IPO falls
Lou Basenese discusses SpaceX's stock falling below its IPO price, attributing it to typical post-IPO drawdowns. He suggests an ideal buy zone around $100 per share based on historical data.
Citi strategist: This isn't an irrational thing for investors to ask
Stuart Kaiser, Citi Head of U.S. Equity Trading Strategy, discusses the semiconductor sector's sell-off due to exhaustion and high equity supply. He questions if elevated valuations make stock issuance more attractive for companies than borrowing.
Market expert: We need this to ‘keep this earnings train moving’
Maria Bartiromo discusses the semiconductor stock sell-off, Big Tech gains, and the Federal Reserve's stance on inflation with Stuart Kaiser and Mark Tepper. They analyze AI investment and market valuations.
Potomac Wealth Advisors: Investors should stay in broad tech, cautious on software
Potomac Wealth Advisors President Mark Avallone advises against rotating out of tech, emphasizing staying invested in broad technology due to phenomenal returns and its economic driving force. He suggests potential underweighting in software.
Stephen Moore: This is the issue of the day
'The Bottom Line' panelists Jason Chaffetz and Stephen Moore respond to skepticism over data centers.
Adam Kobeissi: Don't 'get comfortable' in the AI era
Adam Kobeissi, editor-in-chief of The Kobeissi Letter, warns investors to "never get comfortable" in the AI era on 'Making Money.'
Tom Brady teams with digital health firm eMed to expand GLP-1 weight loss medication access
NFL legend Tom Brady is partnering with eMed to tackle the obesity epidemic by making GLP-1 weight loss medications accessible through employer health benefits.
Portfolio manager explains how he maintains diversification
Allspring Global Investments portfolio manager Matt Wittmer explains how he manages stocks in uncertain times on ‘The Claman Countdown.’
Tom Brady: This is how we can democratize health and wellness like never before
NFL legend and eMed chief wellness officer Tom Brady and eMed CEO Linda Yaccarino discuss eMed's mission on 'The Claman Countdown.'



















